Report a side effect or other safety information

Lundbeck has entered into a partnership with Zuellig Pharma to continue bringing our medicines to patients and healthcare professionals in Singapore. Continuity of care remains our top priority, and together with Zuellig, we are ensuring access to Lundbeck’s medicines and ongoing support for patients and healthcare professionals.

For more information about Zuellig, please visit https://www.zuelligpharma.com. For specific enquiries, please see below.

Singapore

If you want to submit a medical enquiry concerning Abilify, Abilify Maintena, Abilify Asimtufii, or Rexulti, please contact: Medical.Information@apac.otsuka.com

For all other products, please contact: medinfo@zuelligpharma.com

Malaysia

If you want to submit a medical enquiry concerning Abilify, Abilify Maintena, or Rexulti, please contact: HQ_Medinfo@lundbeck.com

For all other products, please contact: medinfo@zuelligpharma.com

For other countries

Please submit medical enquiries to: medinfo@zuelligpharma.com

For Abilify, Abilify Maintena, Abilify Asimtufii, or Rexulti

If you are seeking to report adverse events or submit product quality complaints, please contact: sgop-pv@sg.otsuka.com

For all other products

If you are seeking to report adverse events or submit product quality complaints, please contact: SGZPSPVReporting@zuelligpharma.com